-
Founded in:
2003-09-25 -
Country:
China -
Address:
Middle section of Pingyuan Road, Qionglai City -
Tax NO.:
91510183752833128X -
Registered Funds:
30 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Vitamin A |
It is an essential component for promoting growth, maintaining the visual function of the retina, and maintaining the stability of normal cell membranes. If it is deficient, the body will stop growing, night blindness, dry eyes, and corneal softening will occur.
More
It is an essential component for promoting growth, maintaining the visual function of the retina, and maintaining the stability of normal cell membranes. If it is deficient, the body will stop growing, night blindness, dry eyes, and corneal softening will occur. |
2500IU | 68-26-8 | 2 |
| Vitamin D2 |
Form bone tissue, increase the absorption of calcium and phosphorus, and osteomalacia occurs when calcium and phosphorus are deficient
More
Form bone tissue, increase the absorption of calcium and phosphorus, and osteomalacia occurs when calcium and phosphorus are deficient |
200IU | 50-14-6 | 13 |
| Vitamin E |
Antioxidant effect of cell membrane, acting as oxygen free radical scavenger, deficiency of which causes red blood cell destruction and hemolysis, skeletal muscle and myocardial degeneration
More
Antioxidant effect of cell membrane, acting as oxygen free radical scavenger, deficiency of which causes red blood cell destruction and hemolysis, skeletal muscle and myocardial degeneration |
15mg | 2074-53-5 | 11 |
| Vitamin K1 |
Can form prothrombin to maintain normal blood coagulation function. When it is deficient, it causes prothrombin deficiency bleeding.
More
Can form prothrombin to maintain normal blood coagulation function. When it is deficient, it causes prothrombin deficiency bleeding. |
2mg | 84-80-0 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ondansetron hydrochloride |
This product is a selective 5-HT3 receptor antagonist. Its mechanism of action may be to antagonize the 5-HT3 receptors in the peripheral vagus nerve endings and central chemoreceptor areas, thereby blocking the vomiting reflex caused by factors such as chemotherapy and surgery that promote the release of 5-HT from intestinal chromaffin cells and excite the vagus afferent nerves. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.
More
This product is a selective 5-HT3 receptor antagonist. Its mechanism of action may be to antagonize the 5-HT3 receptors in the peripheral vagus nerve endings and central chemoreceptor areas, thereby blocking the vomiting reflex caused by factors such as chemotherapy and surgery that promote the release of 5-HT from intestinal chromaffin cells and excite the vagus afferent nerves. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation. |
103639-04-9 | 26 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pefloxacin mesylate |
Quinolone antibacterial drugs inhibit bacterial DNA helicase and have strong antibacterial activity against Enterobacter bacteria such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc., as well as influenza bacillus and Neisseria. They also have certain antibacterial effects on Staphylococcus aureus and Pseudomonas aeruginosa. They have only mild effects on pneumococci, various groups of streptococci and enterococci.
More
Quinolone antibacterial drugs inhibit bacterial DNA helicase and have strong antibacterial activity against Enterobacter bacteria such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc., as well as influenza bacillus and Neisseria. They also have certain antibacterial effects on Staphylococcus aureus and Pseudomonas aeruginosa. They have only mild effects on pneumococci, various groups of streptococci and enterococci. |
70458-95-6 | 4 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acyclovir |
This product is a synthetic nucleoside antiviral drug, which has inhibitory effects on herpes simplex virus type I (HSV-1), type H (HSV-2) and varicella-zoster virus (VZV) in vivo and in vitro. Cell culture results show that this product has the strongest inhibitory effect on HSV-1 virus, followed by HSV-2 and VZV virus. Because this product has affinity for thymidine kinase (TK) encoded by HSV and VZV, it has a highly selective inhibitory effect. This type of viral enzyme converts acyclovir into acyclovir monophosphate, a nucleoside analog. The monophosphate is further converted into diphosphate by guanylate kinase in the cell, and then converted into triphosphate by multiple enzymes in the cell. In vitro, acyclovir triphosphate stops herpes virus DNA replication.
More
This product is a synthetic nucleoside antiviral drug, which has inhibitory effects on herpes simplex virus type I (HSV-1), type H (HSV-2) and varicella-zoster virus (VZV) in vivo and in vitro. Cell culture results show that this product has the strongest inhibitory effect on HSV-1 virus, followed by HSV-2 and VZV virus. Because this product has affinity for thymidine kinase (TK) encoded by HSV and VZV, it has a highly selective inhibitory effect. This type of viral enzyme converts acyclovir into acyclovir monophosphate, a nucleoside analog. The monophosphate is further converted into diphosphate by guanylate kinase in the cell, and then converted into triphosphate by multiple enzymes in the cell. In vitro, acyclovir triphosphate stops herpes virus DNA replication. |
59277-89-3 | 50 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ribavirin |
Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.
More
Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus. |
36791-04-5 | 33 |